a developer of oncology therapeutics for treatment of solid and hematologic cancers
Industry Biotechnology
A.I.dvisor indicates that over the last year, VIRX has been loosely correlated with MRNS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VIRX jumps, then MRNS could also see price increases.
Ticker / NAME | Correlation To VIRX | 1D Price Change % | ||
---|---|---|---|---|
VIRX | 100% | +11.42% | ||
MRNS - VIRX | 40% Loosely correlated | +2.14% | ||
VNDA - VIRX | 27% Poorly correlated | -3.97% | ||
SPRO - VIRX | 25% Poorly correlated | -2.19% | ||
CTMX - VIRX | 25% Poorly correlated | -5.08% | ||
IMMP - VIRX | 24% Poorly correlated | -3.80% | ||
More |
Ticker / NAME | Correlation To VIRX | 1D Price Change % |
---|---|---|
VIRX | 100% | +11.42% |
treatment theme (61 stocks) | 14% Poorly correlated | +0.91% |
therapeutics theme (57 stocks) | 11% Poorly correlated | +20.54% |
drugs theme (265 stocks) | 10% Poorly correlated | +5.37% |
biotechnology theme (248 stocks) | 8% Poorly correlated | +5.56% |
oncology theme (18 stocks) | 4% Poorly correlated | +0.37% |